These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35269932)
1. Molecular Research in Multiple Sclerosis. Fucito M; Pieragostino D Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269932 [TBL] [Abstract][Full Text] [Related]
2. miRNA in multiple sclerosis: search for novel biomarkers. Gandhi R Mult Scler; 2015 Aug; 21(9):1095-103. PubMed ID: 25921051 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. Pravica V; Popadic D; Savic E; Markovic M; Drulovic J; Mostarica-Stojkovic M Immunol Res; 2012 Apr; 52(1-2):42-52. PubMed ID: 22392049 [TBL] [Abstract][Full Text] [Related]
6. Recent advances of long noncoding RNAs involved in the development of multiple sclerosis. Li QW; Lei W; Chen C; Guo W Chin J Nat Med; 2020 Jan; 18(1):36-46. PubMed ID: 31955822 [TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: from molecules to treatment. Broadley SA Int J Mol Sci; 2013 Apr; 14(4):7598-602. PubMed ID: 23612323 [TBL] [Abstract][Full Text] [Related]
8. Plasmatic microRNA as Potential Biomarkers of Multiple Sclerosis: Literature Review. Kacperska MJ; Walenczak J; Tomasik B Adv Clin Exp Med; 2016; 25(4):775-9. PubMed ID: 27629854 [TBL] [Abstract][Full Text] [Related]
9. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview. Piket E; Zheleznyakova GY; Kular L; Jagodic M J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917 [TBL] [Abstract][Full Text] [Related]
13. Genetics for understanding and predicting clinical progression in multiple sclerosis. Depaz R; Granger B; Cournu-Rebeix I; Bouafia A; Fontaine B Rev Neurol (Paris); 2011 Nov; 167(11):791-801. PubMed ID: 21683424 [TBL] [Abstract][Full Text] [Related]
14. [Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]. Fontaine B Rev Neurol (Paris); 2012 Nov; 168(11):833-5. PubMed ID: 22959703 [TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of OIP5-AS1/HUR1 to discover new potential biomarkers and therapeutic targets in multiple sclerosis. Gharesouran J; Taheri M; Sayad A; Mazdeh M; Omrani MD J Cell Physiol; 2019 Aug; 234(10):17351-17360. PubMed ID: 30815864 [TBL] [Abstract][Full Text] [Related]